Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Dunlop

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
The European Journal of Neuroscience|January 9, 2023
Site-specific inhibition of the thalamic reticular nucleus induces distinct modulations in sleep architectureVladimir Visocky, Brian J Morris, John Dunlop, et al.
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
Ion channel screeningJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Neuron|December 3, 2014
Improving and accelerating drug development for nervous system disordersDiana E Pankevich, Bruce M Altevogt, John Dunlop, et al.
Brain Research|February 21, 2006
Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathwayH Beal McIlvain, Andreas Baudy, Kelly Sullivan, et al.
Assay and Drug Development Technologies|March 2, 2006
Validation of DRG-like F11 cells for evaluation of KCNQ/M-channel modulatorsFlora Jow, Lan He, Angela Kramer, et al.
Assay and Drug Development Technologies|September 2, 2006
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373)Flora Jow, Eugene Tseng, Taneya Maddox, et al.
Biochemical and Biophysical Research Communications|June 12, 2002
The C-terminus of Gi family G-proteins as a determinant of 5-HT(1A) receptor couplingDianne Kowal, Jean Zhang, Stanley Nawoschik, et al.
European Journal of Pharmacology|December 29, 2007
Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assayYan T Lee, Dmitry V Vasilyev, Qin J Shan, et al.
Assay and Drug Development Technologies|November 20, 2009
Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligandsJean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, et al.
CNS Drug Reviews|January 18, 2007
Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indicationsJohn Dunlop, Karen L Marquis, H K Lim, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
The European Journal of Neuroscience|January 9, 2023
Site-specific inhibition of the thalamic reticular nucleus induces distinct modulations in sleep architectureVladimir Visocky, Brian J Morris, John Dunlop, et al.
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
Ion channel screeningJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Neuron|December 3, 2014
Improving and accelerating drug development for nervous system disordersDiana E Pankevich, Bruce M Altevogt, John Dunlop, et al.
Brain Research|February 21, 2006
Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathwayH Beal McIlvain, Andreas Baudy, Kelly Sullivan, et al.
Assay and Drug Development Technologies|March 2, 2006
Validation of DRG-like F11 cells for evaluation of KCNQ/M-channel modulatorsFlora Jow, Lan He, Angela Kramer, et al.
Assay and Drug Development Technologies|September 2, 2006
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373)Flora Jow, Eugene Tseng, Taneya Maddox, et al.
Biochemical and Biophysical Research Communications|June 12, 2002
The C-terminus of Gi family G-proteins as a determinant of 5-HT(1A) receptor couplingDianne Kowal, Jean Zhang, Stanley Nawoschik, et al.
European Journal of Pharmacology|December 29, 2007
Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assayYan T Lee, Dmitry V Vasilyev, Qin J Shan, et al.
Assay and Drug Development Technologies|November 20, 2009
Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligandsJean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, et al.
CNS Drug Reviews|January 18, 2007
Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indicationsJohn Dunlop, Karen L Marquis, H K Lim, et al.
Pageof 10